Pre-clinical symposium
IOF-ESCEO 3rd Pre-clinical Symposium
Third European Preclinical Conference on musculo-skeletal disorders
09:00 - 09:10
Ellisse
Welcome
Anna Teti.
09:10 - 09:30
Ellisse
Invited Lecture 1
Chairperson(s): Roger Fielding, Hans van Leeuwen.
- How do rare genetic diseases contribute to the understanding of common bone diseases? The contribution of chondrodysplasias to the understanding of osteoarthritis - Michael Briggs
09:30 - 09:50
Ellisse
Invited Lecture 2
Chairperson(s): Roger Fielding, Hans van Leeuwen.
- How do rare genetic diseases contribute to the understanding of common bone diseases? The contribution of osteodysplasias to the understanding of osteoporosis - Wim van Hul
09:50 - 10:10
Ellisse
Invited Lecture 3
Chairperson(s): Roger Fielding, Hans van Leeuwen.
- How do preclinical studies offer new options for future developments?
Future molecular therapies for osteoporosis - Lorenz C. Hofbauer
10:10 - 10:30
Ellisse
Invited Lecture 4
Chairperson(s): Roger Fielding, Hans van Leeuwen.
- How do preclinical studies offer new options for future developments?
New potential developments using siRNA and small peptides - Anna Teti
10:30 - 10:50
Ellisse
Invited Lecture 5
Chairperson(s): Anna Teti, Michael Briggs.
- How does the skeleton impact muscle cells?
Vascular calcification - Catherine Shanahan
10:50 - 11:10
Ellisse
Invited Lecture 6
Chairperson(s): Anna Teti, Michael Briggs.
- How does the skeleton impact muscle cells?
Key regulators of muscle-bone unit - Roger Fielding
11:10 - 11:30
Ellisse
Invited Lecture 7
Chairperson(s): Anna Teti, Michael Briggs.
- The 2Cl-/H+-exchanger ClC-7/Ostm1 is required for bone resorption and lysosomal function. - Stefanie Weinert
11:30 - 11:50
Ellisse
Invited Lecture 8
Chairperson(s): Anna Teti, Michael Briggs.
- How does the skeleton contribute to ion metabolism
Cation transport mechanisms and diseases - Hans van Leeuwen
